Novo Owner Commits $265 Million Of Wegovy Windfall to Respiratory Diseases Novo Owner Commits $265 Million Of Wegovy Windfall to Respiratory Diseases

The Novo Nordisk Foundation, which controls drug maker Novo Nordisk, said on Monday it would commit up to 1.8 billion Danish crowns ($265 million) to setting up an...Reuters Health Information
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Pulmonary Medicine Source Type: news